• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LAT1与疾病的相关性综述:机制与治疗

Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment.

作者信息

Zhang Jingshun, Xu Ying, Li Dandan, Fu Lulu, Zhang Xueying, Bao Yigang, Zheng Lianwen

机构信息

Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China.

出版信息

Front Chem. 2020 Oct 20;8:564809. doi: 10.3389/fchem.2020.564809. eCollection 2020.

DOI:10.3389/fchem.2020.564809
PMID:33195053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7606929/
Abstract

LAT1 is a member of the system L transporter family. The main role of the LAT1 is to transport specific amino acids through cell membranes to provide nutrients to cells and participate in several metabolic pathways. It also contributes to the transport of hormones and some drugs, which are essential for the development and treatment of some diseases. In recent years, many studies have shown that LAT1 is related to cancer, obesity, diabetes, and other diseases. However, the specific mechanism underlying the influence of LAT1 on such conditions remains unclear. Through the increasing number of studies on LAT1, we have obtained a preliminary understanding on the function of LAT1 in diseases. These studies also provide a theoretical basis for finding treatments for LAT1-related diseases, such as cancer. This review summarizes the function and mechanism of LAT1 in different diseases and the treatment of LAT1-related diseases. It also provides support for the development of novel and reliable disease treatments.

摘要

LAT1是L系统转运蛋白家族的成员。LAT1的主要作用是通过细胞膜转运特定氨基酸,为细胞提供营养并参与多种代谢途径。它还有助于激素和一些药物的转运,而这些对于某些疾病的发展和治疗至关重要。近年来,许多研究表明LAT1与癌症、肥胖症、糖尿病及其他疾病有关。然而,LAT1影响这些病症的具体机制仍不清楚。通过对LAT1越来越多的研究,我们对LAT1在疾病中的功能有了初步了解。这些研究也为寻找LAT1相关疾病(如癌症)的治疗方法提供了理论基础。本综述总结了LAT1在不同疾病中的功能和机制以及LAT1相关疾病的治疗方法。它还为开发新颖可靠的疾病治疗方法提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8775/7606929/ab2c5e9ac671/fchem-08-564809-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8775/7606929/ab2c5e9ac671/fchem-08-564809-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8775/7606929/ab2c5e9ac671/fchem-08-564809-g0001.jpg

相似文献

1
Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment.LAT1与疾病的相关性综述:机制与治疗
Front Chem. 2020 Oct 20;8:564809. doi: 10.3389/fchem.2020.564809. eCollection 2020.
2
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.L 型氨基酸转运蛋白 1(LAT1)在癌症中的作用。
Curr Cancer Drug Targets. 2019;19(11):863-876. doi: 10.2174/1568009619666190802135714.
3
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.用于选择性和高效的 l 型氨基酸转运体 1(LAT1)介导的细胞摄取的结构特性。
Int J Pharm. 2018 Jun 10;544(1):91-99. doi: 10.1016/j.ijpharm.2018.04.025. Epub 2018 Apr 15.
4
The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.L 型氨基酸转运蛋白 1(LAT1)在癌症中的调控与功能。
Int J Mol Sci. 2018 Aug 12;19(8):2373. doi: 10.3390/ijms19082373.
5
Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).新型癌症类型转运蛋白L型氨基酸转运体1(LAT1)抑制剂系列的构效关系
J Pharmacol Sci. 2017 Feb;133(2):96-102. doi: 10.1016/j.jphs.2017.01.006. Epub 2017 Feb 9.
6
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.深入了解人氨基酸转运蛋白 LAT1(SLC7A5)的转运机制。探究底物转运的关键残基。
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):727-736. doi: 10.1016/j.bbagen.2017.01.013. Epub 2017 Jan 11.
7
c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells.c-Myc 对于 MIA Paca-2 人胰腺癌细胞中 LAT1 的表达至关重要。
Oncol Rep. 2012 Sep;28(3):862-6. doi: 10.3892/or.2012.1878. Epub 2012 Jun 20.
8
The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.L 型氨基酸转运蛋白 LAT1:癌症治疗的新兴靶点
Int J Mol Sci. 2019 May 16;20(10):2428. doi: 10.3390/ijms20102428.
9
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.T24人膀胱癌细胞中系统L氨基酸转运体的特性研究
Biochim Biophys Acta. 2002 Sep 20;1565(1):112-21. doi: 10.1016/s0005-2736(02)00516-3.
10
L-type amino acid transporter 1 expression is upregulated and associated with cellular proliferation in colorectal cancer.L型氨基酸转运体1的表达上调,且与结直肠癌的细胞增殖相关。
Oncol Lett. 2017 Dec;14(6):7410-7416. doi: 10.3892/ol.2017.7148. Epub 2017 Oct 6.

引用本文的文献

1
KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis.KRAS 突变通过 ZNF24/SLC7A5/PD-L1 轴促进肺腺癌的免疫逃逸。
BMC Cancer. 2025 Sep 2;25(1):1417. doi: 10.1186/s12885-025-14336-0.
2
Multi-omics signature of healthy versus unhealthy lifestyles reveals associations with diseases.健康与不健康生活方式的多组学特征揭示了与疾病的关联。
Hum Genomics. 2025 Aug 30;19(1):101. doi: 10.1186/s40246-025-00817-7.
3
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review).

本文引用的文献

1
L-Type amino acid transporter 1 as a target for drug delivery.L 型氨基酸转运蛋白 1 作为药物递送的靶点。
Pharm Res. 2020 May 6;37(5):88. doi: 10.1007/s11095-020-02826-8.
2
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors.首个人体 I 期研究 JPH203,一种 L 型氨基酸转运蛋白 1 抑制剂,在晚期实体瘤患者中的研究。
Invest New Drugs. 2020 Oct;38(5):1495-1506. doi: 10.1007/s10637-020-00924-3. Epub 2020 Mar 20.
3
Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
L型氨基酸转运体1在增强硼中子俘获治疗中的作用:机制、挑战与未来方向(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5611. Epub 2025 Aug 24.
4
Prognostic value of pre-treatment metabolic tumor volume on [S‑methyl‑C]‑L‑methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy.局部非小细胞肺癌患者单次分割碳离子放疗前代谢肿瘤体积对[S-甲基-C]-L-蛋氨酸PET/CT的预后价值
Ann Nucl Med. 2025 Jun 30. doi: 10.1007/s12149-025-02067-y.
5
SLC7 transporters at the crossroads of amino acid metabolism and diabetes pathophysiology: insights and therapeutic perspectives.SLC7转运蛋白处于氨基酸代谢与糖尿病病理生理学的交叉点:见解与治疗前景
Front Nutr. 2025 May 21;12:1467057. doi: 10.3389/fnut.2025.1467057. eCollection 2025.
6
FastConformation: A Standalone ML-Based Toolkit for Modeling and Analyzing Protein Conformational Ensembles at Scale.FastConformation:一个用于大规模建模和分析蛋白质构象集合的基于机器学习的独立工具包。
bioRxiv. 2025 May 14:2025.05.09.653048. doi: 10.1101/2025.05.09.653048.
7
Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study.肥胖和新发2型糖尿病患者胰腺左旋多巴摄取的变化:一项18F-FDOPA PET-CT研究
Front Endocrinol (Lausanne). 2025 Mar 3;16:1460253. doi: 10.3389/fendo.2025.1460253. eCollection 2025.
8
Targeting Surface Markers in Anaplastic Thyroid Cancer: Future Directions in Ligand-bound Therapy.靶向间变性甲状腺癌中的表面标志物:配体结合疗法的未来方向
J Endocr Soc. 2025 Feb 27;9(4):bvaf035. doi: 10.1210/jendso/bvaf035. eCollection 2025 Mar 3.
9
The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.血脑屏障在神经退行性疾病中的关键作用:破坏机制及治疗意义
J Clin Med. 2025 Jan 9;14(2):386. doi: 10.3390/jcm14020386.
10
Identification of potential biomarkers from amino acid transporter in the activation of hepatic stellate cells via bioinformatics.通过生物信息学从氨基酸转运蛋白中鉴定肝星状细胞激活过程中的潜在生物标志物。
Front Genet. 2024 Dec 4;15:1499915. doi: 10.3389/fgene.2024.1499915. eCollection 2024.
靶向固有和适应性 T 细胞中的 L 型氨基酸转运蛋白 1 可有效控制皮肤炎症。
J Allergy Clin Immunol. 2020 Jan;145(1):199-214.e11. doi: 10.1016/j.jaci.2019.09.025. Epub 2019 Oct 9.
4
L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia.L 型氨基酸转运蛋白 1(LAT1/Lat1)-利用前药可以改善药物向神经元、星形胶质细胞和小胶质细胞的递送。
Sci Rep. 2019 Sep 6;9(1):12860. doi: 10.1038/s41598-019-49009-z.
5
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.MYC 通过色氨酸降解途径促进结肠癌中色氨酸的摄取和代谢。
Genes Dev. 2019 Sep 1;33(17-18):1236-1251. doi: 10.1101/gad.327056.119. Epub 2019 Aug 15.
6
Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets.l 型氨基酸转运体 1 用于酮洛芬前药脑内给药的机制研究:一种支持细胞内靶向前药开发的新方法。
Mol Pharm. 2019 Jul 1;16(7):3261-3274. doi: 10.1021/acs.molpharmaceut.9b00502. Epub 2019 Jun 18.
7
The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.L 型氨基酸转运蛋白 LAT1:癌症治疗的新兴靶点
Int J Mol Sci. 2019 May 16;20(10):2428. doi: 10.3390/ijms20102428.
8
Obesity Reduces mTORC1 Activity in Mucosal-Associated Invariant T Cells, Driving Defective Metabolic and Functional Responses.肥胖会降低黏膜相关不变 T 细胞中 mTORC1 的活性,从而导致代谢和功能反应受损。
J Immunol. 2019 Jun 15;202(12):3404-3411. doi: 10.4049/jimmunol.1801600. Epub 2019 May 10.
9
Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma.LAT1 表达模式与卵巢透明细胞癌化疗耐药性之间存在显著关系。
Virchows Arch. 2019 Jun;474(6):701-710. doi: 10.1007/s00428-019-02520-0. Epub 2019 Jan 13.
10
L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.L 型氨基酸转运体 1 利用阿魏酸前药揭示了支持脑递药前药设计的结构特征。
Eur J Pharm Sci. 2019 Mar 1;129:99-109. doi: 10.1016/j.ejps.2019.01.002. Epub 2019 Jan 6.